Exact Sciences acquired exclusive rights in the US and received a premarket application to the FDA from Freenome, alongside publishing study findings in JAMA.

The entities involved

• Exact Sciences →

  American company in Madison, United States

  • Zacks Investment Research provided stock analysis and ratings for Exact Sciences.Sun 06:59
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• The FDA is monitoring drug industry practices and pricing, utilizing studies published by JAMA.Sep 10
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• Elutia is trading on the Nasdaq stock exchange and requires regulatory clearance from the FDA for product launches.Aug 15
• Mylan is seeking regulatory approval from the FDA for new products and has listed its stock on the Nasdaq exchange.Sep 2
• PAVmed is facing the requirement of regulatory clearance for its company products, while also attracting institutional investment interest.Sep 5